Immunoforge Co. Ltd.: Clinical Trials

1 trial sponsored by Immunoforge Co. Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Immunoforge Co. Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy
Froniglutide, Placebo - Dermatomyositis, Polymyositis
Phase 2UnknownImmunoforge Co. Ltd.392023-09-052023-09-13

Conditions studied

Dermatomyositis (1)  ·  Myositis (1)  ·  Polymyositis (1)

Countries

South Korea (1)